drugset / Trial / NCT02667938
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules
RandomizedParallel-groupDouble-blindTreatment
Summary
The main objective of this study is to evaluate efficacy and safety of HCP1301 capsule in patients with Benign Prostatic Hyperplasia and Erectile Dysfunction
Timeline
- Start
- 2015-03
- Primary completion
- 2016-01
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HCP1303 | Unknown | 0.2 mg | — |
| Subject | HCP1303 | Unknown | 0.4 mg | — |
| Comparator | HGP1201 | Unknown | — | — |